SHCNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

Sotera Health Co

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$17.64−0.25 (-1.40%)

Close on Oct 19, 2026

Market cap: $5.08B
P/E (TTM): 30.9
Dividend yield: –

Sotera Health Co cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Depreciation & Amortization	95	84	77	64	64	63	67
Stock-Based Compensation	31	37	32	21	14	11	6.88
Deferred Income Taxes	0.02	9.43	3.45	-74	-3.72	-23	-19
Other Non-Cash Items	4.28	5.37	5.32	6.99	13	5.54	5.22
Change in Accounts Receivable	7.15	2.22	-22	-13	-16	1.94	12
Change in Inventory	-2.38	-4.75	-9.97	14	-20	3.78	-0.28
Change in Accounts Payable	5.19	-6.64	-5.33	1.11	20	-6.02	-8.97
Operating Cash Flow	287	224	-148	278	282	121	149
Capital Expenditures	-138	-179	-215	-182	-102	-54	-57
Acquisitions	–	–	0	0	-14	0	0
Other Investing Activities	2.87	0.07	0.07	0.03	-0.70	0	0
Investing Cash Flow	-135	-179	-215	-182	-160	-159	-57
Dividends Paid	–	–	–	–	0	0	-691
Share Repurchases	–	–	–	0	0	-34	0
Stock Issued	–	–	–	0	0	1,156	0
Debt Issued	0	2,259	500	200	0	150	3,145
Debt Repaid	-86	-2,264	-2.50	0	-100	-1,177	-2,561
Taxes Paid on Share-Based Awards	-6.57	-4.43	-4.09	-0.39	-1.43	0	0
Other Financing Activities	-3.49	-2.31	-1.81	-1.82	-0.64	-1.46	-1.34
Financing Cash Flow	-101	-51	266	198	-117	73	-126
Foreign Exchange Rate Adjustments	16	-17	2.04	-4.46	0.04	4.11	0.49
Net Change in Cash	68	-23	-95	289	4.47	39	-34
Free Cash Flow	149	45	-363	96	179	67	92
Income Taxes Paid	61	66	50	75	52	24	45
Interest Paid	164	180	174	76	59	211	151

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 55.0%
Operating margin: –
Net margin: 13.4%
Return on equity, FY2025: 15.4%

Financial strength

Current ratio: 2.80
Debt to equity: 3.21
Debt to assets: 64.7%
Cash to current liabilities: 154.3%

Valuation

P/E ratio: 30.9
Price to sales: 4.18
Price to book: 7.64
Dividend yield: –